Intellia Therapeutics
NTLA
#5563
Rank
C$1.47 B
Marketcap
$14.49
Share price
-3.62%
Change (1 day)
-59.57%
Change (1 year)

Earnings for Intellia Therapeutics (NTLA)

Earnings in 2024 (TTM): -C$0.71 Billion

According to Intellia Therapeutics's latest financial reports the company's current earnings are C$43.08 Million. In 2023 the company made an earning of -C$0.69 Billion a decrease over its 2022 earnings that were of -C$0.68 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Intellia Therapeutics from 2015 to 2024

Annual earnings

Year Earnings Change
2024 (TTM) -C$0.71 Billion2.49%
2023 -C$0.69 Billion1.48%
2022 -C$0.68 Billion77.01%
2021 -C$0.39 Billion99.58%
2020 -C$0.2 Billion34.86%
2019 -C$0.15 Billion16.63%
2018 -C$0.13 Billion26.35%
2017 -C$96.61 Million113.51%
2016 -C$45.25 Million135.92%
2015 -C$19.18 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
-C$0.2 Billion-74.20%๐Ÿ‡บ๐Ÿ‡ธ USA